Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecopipam in Children and Adolescents With Tourette's Syndrome
NCT04007991Phase 2Completed
- Sponsor
- Emalex Biosciences
- Start
- Jun 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ecopipam in Tourette syndrome (TS), sponsored by Emalex Biosciences. Started Jun 2019; status: completed.
02
Drugs
ecopipam
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT04007991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04007991.